Lates News
DiZe Pharmaceuticals: Shuwozhe compared with platinum-based chemotherapy completed first-line treatment for advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutation in a global multicenter phase III clinical trial.
Latest